Osteogenic Act Peptide ( 1141 ) ion in of Parathyroid Rat ROS Cells Hormone-Related

To examine the autocrine/paracrine effect of parathyroid hormone-related peptide (PTHrP) on osteoblast function, the entire coding region of rat PTHrP (1-141) cDNA inserted into the expression vector was stably transfected into the rat clonal strain of the osteoblast-like cell, ROS 17/2.8, and established stable transfectants. Using the PTHrP-overexpressing ROS cells (ROS/PLP/6), we analyzed in vitro cell characterization and in vivo osteogenic properties. As expected, overexpression of endogenous PTHrP in vitro induced PTH/PTHrP receptor down-regulation confirmed by Northern blots, receptor binding assays, and functional analysis. The established transfectants indicated a decreased growth rate compared with the original non-transfected ROS 17/2.8. Although cAMP production induced by exogenous PTH was suppressed in ROS/PLP/6, the stimulatory effects of forskolin and chorela toxin showed no significant difference between the original ROS 17/2.8 and transfected cells, but the in vivo osteogenic properties were histologically potentiated in transfectants with increased bone matrix and acceleration of mineralization within tumors. The levels of osteocalcin and osteopontin mRNAs were also increased in transfectants. The down-regulated in vitro PTH/PTHrP receptor mRNA was restored in in vivo tumor tissues. Our study provides clear evidence that the in vivo osteogenic function in ROS cells is potentiated by PTHrP, through an autocrine/paracrine mode of action.

[1]  L. Bonewald,et al.  Matrix vesicles produced by osteoblast-like cells in culture become significantly enriched in proteoglycan-degrading metalloproteinases after addition of β-Glycerophosphate and ascorbic acid , 1994, Calcified Tissue International.

[2]  F. Trotta,et al.  PREPARATION AND CHARACTERIZATION OF , 1996 .

[3]  R. Turner,et al.  Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. , 1995, Endocrinology.

[4]  R. Turner,et al.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. , 1995, Endocrinology.

[5]  G. Roodman,et al.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. , 1995, The Journal of clinical investigation.

[6]  G. Segre,et al.  Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. , 1995, Endocrinology.

[7]  G. Stein,et al.  Nuclear architecture supports integration of physiological regulatory signals for transcription of cell growth and tissue‐specific genes during osteoblast differentiation , 1994, Journal of cellular biochemistry.

[8]  T. Martin,et al.  The parathyroid hormone-related protein gene and its expression , 1994, Molecular and Cellular Endocrinology.

[9]  T. Martin,et al.  Carboxyl‐terminal parathyroid hormone‐related protein inhibits bone resorption by isolated chicken osteoclasts , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  P. Esbrit,et al.  Proliferative effect of parathyroid hormone-related protein on the hypercalcemic Walker 256 carcinoma cell line. , 1994, Biochemical and biophysical research communications.

[11]  J Glowacki,et al.  Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. , 1994, Genes & development.

[12]  G S Stein,et al.  Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. , 1993, Endocrine reviews.

[13]  H. Kronenberg,et al.  Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells. , 1993, Endocrinology.

[14]  H. Namba,et al.  Autocrine/paracrine function of parathyroid hormone-related peptide in rat osteoblast-like cells. , 1993, Biochemical and biophysical research communications.

[15]  E. Ogata,et al.  Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E1 in HTLV-I-infected T cells. , 1993, The Journal of biological chemistry.

[16]  H. Jüppner,et al.  Parathyroid hormone-related peptide as an endogenous inducer of parietal endoderm differentiation , 1993, The Journal of cell biology.

[17]  H. Jüppner,et al.  In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats. , 1992, Bone.

[18]  G. Mundy.  Cytokines of Bone , 1993 .

[19]  T. Martin,et al.  Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells. , 1992, Endocrinology.

[20]  D. Bruns,et al.  Abundant expression of parathyroid hormone-related protein in human amnion and its association with labor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Quirke,et al.  Parathyroid hormone‐related peptide: Expression in fetal and neonatal development , 1992, The Journal of pathology.

[22]  M. Freeman,et al.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Rhim,et al.  Identification and functional characterization of adenylate cyclase-linked receptors for parathyroid hormone-like peptides on immortalized human keratinocytes. , 1992, Endocrinology.

[24]  T. Martin,et al.  A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111]. , 1991, Endocrinology.

[25]  R. Kitazawa,et al.  Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry. , 1991, Bone and mineral.

[26]  H. Jüppner,et al.  Preparation and characterization of [N alpha-(4-azido-2-nitrophenyl)Ala1,Tyr36]-parathyroid hormone related peptide (1-36)amide: a high-affinity, partial agonist having high cross-linking efficiency with its receptor on ROS 17/2.8 cells. , 1990, Biochemistry.

[27]  J. Klein-Nulend,et al.  Comparison of the effects of synthetic human parathyroid hormone (PTH)-(1-34)-related peptide of malignancy and bovine PTH-(1-34) on bone formation and resorption in organ culture. , 1990, Endocrinology.

[28]  J. Orloff,et al.  Parathyroid hormone-like proteins: biochemical responses and receptor interactions. , 1989, Endocrine reviews.

[29]  A. Broadus,et al.  Isolation and characterization of the human parathyroid hormone-like peptide gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Suva,et al.  Parathyroid hormone-related protein: a novel gene product. , 1988, Bailliere's clinical endocrinology and metabolism.

[31]  G. Strewler,et al.  Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. , 1987, The Journal of clinical investigation.

[32]  J. Heersche,et al.  Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. , 1982, Endocrinology.